Key result
Sustained VT or complete heart block at presentation predicts major cardiovascular events in acute myocarditis with ~30% risk.
Why the study?
The clinical presentations, aetiologies, and outcomes of patients presenting with acute myocarditis in South Africa were not well established.
Cohort (n=111)
No
Answers are grounded in this paper and cite their sources.
In a South African cohort of acute myocarditis, viral pathogens were common, and initial presentation with sustained ventricular tachycardia or complete heart block strongly predicted major adverse clinical events.
AIMS: This study aims to determine the clinical presentations, aetiologies and outcomes of patients presenting with acute myocarditis (AM) in South Africa. METHODS: This is a prospective cohort study. Consecutive patients presenting to Tygerberg Hospital, Cape Town, South Africa, between August 2017 and November 2021 who fulfilled the European Society of Cardiology diagnostic criteria for clinically suspected myocarditis undergoing all recommended investigations, including cardiac MRI (CMR) and endomyocardial biopsy (EMB), were included. RESULTS: 111 cases (mean age 41.2 years, 66.3% male) of clinically suspected myocarditis were recruited. AM was confirmed in 89: 44 (49.4%) on CMR only, 16 (18.0%) on EMB only and 29 (32.6%) on both CMR and EMB. 46 (51.7%) presented with infarct-like symptoms, 31 (34.8%) presented with heart failure (HF), 8 (9.0%) with sustained ventricular tachycardia (VT) and 4 (4.5%) with complete heart block (CHB). Viral pathogens were detected in 52 (58.4%) patients with AM, with Parvovirus B19 the most frequent in 39 (75.0%) as monoinfection and as coinfection in 4 (3 (5.8%) with Epstein-Barr virus (EBV) and 1 (1.9%) with EBV and human herpesvirus 6. The prespecified adverse outcome, defined as the occurrence of major adverse clinical events, including cardiac death, documented sustained VT, recurrence of AM and HF hospitalisation, occurred in 30.3%. Initial presentation with sustained VT (HR 5.36, 95% CI 1.76 to 16.33, p=0.003) or CHB (HR 5.67, 95% CI 1.38 to 23.26, p=0.016) was a significant predictor of adverse outcome on multivariate analysis. CONCLUSION: We report data from the largest cohort of patients with AM outside of the developed world. It provides insight into the clinical presentation, aetiology, viral pathogens and outcomes of patients with AM locally. The findings in this cohort from Africa appear similar to the developed world.
No takes yet. Share an insight, caveat, or question.
Hassan et al. (2025) conducted a cohort in acute myocarditis (n=111). In a South African cohort of acute myocarditis, major adverse clinical events occurred in 30.3% of patients, with initial presentation of sustained VT or complete heart block predicting adverse outcomes.
Synapse has enriched 10 related papers. Consider them for comparative context: